Clinical TrialsSearch results
Number of results: 830
Other
- A phase II trial of concurrent chemoradiotherapy with 5-FU plus cisplatin for resectable squamous cell carcinoma of cervical esophagus
- cervical esophageal cancer
- National Cancer Center Hospital
- 2009-01-05
Other
- A phase II trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced esophageal carcinoma (KDOG 0501 P2)
- locally advanced esophageal carcinoma
- Kitasato University School of Medicine
- 2009-06-01
Other
- A phase II trial of endoscopic submucosal dissection (ESD) for superficial esophageal cancer (KDOG 0901)
- Superficial esophageal cancer
- Kitasato University School of Medicine
- 2009-06-04
Other
- A phase II trial of pre-operative chemoradiotherapy followed by surgical resection in Pancoast tumors: initial report of Japan Clinical Oncology Group trial (JCOG 9806)
- pulmonary neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-07-28
Other
- A Phase II trial of S-1 and concurrent radiotherapy for locally advanced pancreatic cancer
- Locally advanced pancreatic cancer
- Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital
- 2006-09-12
Other
- A phase II/III clinical study of R442(Pegylated Interferon alfa-2a) for patients with chronic hepatitis B.
- chronic hepatitis B
- CHUGAI PHARMACEUTICAL CO.LTD.
- 2007-04-26
Recruiting
- A phase II/III study of NPC-22
- chronic sialorrhea
- Miyoshi Katsunori
- 2024-06-14
Completed
- A Phase III Investigator Initiated Clinical Trial Evaluating the Efficacy and Safety of CNS7056 (Remimazolam) With a Concomitant Use of Opioid Analgesics in Japanese Patients Undergoing Gastrointestinal Endoscopy
- Japanese patients undergoing gastrointestinal endoscopy in combination with a concomitant use of opi
- Ikehara Hisatomo
- 2022-06-11
Completed
- A Phase III Long Term Study of K-877 Extended Release Tablet
- Dyslipidemia
- Tanigawa Ryohei
- 2021-02-05
Recruiting
- A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor low/HER2-negative Breast Cancer
- Breast Cancer
- Inoguchi Akihiro
- 2024-03-20